Bioverativ Therapeutics Inc.

MA · United States · Reporting entity ID 100000181764

Total reported 2019–2025

$11.1M

#459 of 2,960 reporting companies — 0% of all reported industry payments

$4.38M in general payments across 1,032 records, plus $6.70M in research funding across 1,733 records.

How it breaks down

General payments $4,377,273

Research funding $6,702,493

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.